Navigation Links
Endologix Reports 47% Third Quarter 2009 Revenue Growth
Date:10/27/2009

the year ended December 31, 2008, and the Company's other filings with the Securities and Exchange Commission, for more detailed information regarding these risks and other factors that may cause actual results to differ materially from those expressed or implied.

                               ENDOLOGIX, INC.
                CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                  (In thousands, except per share amounts)
                               (Unaudited)


                                  Three Months Ended   Nine Months Ended
                                     September 30,       September 30,
                                    2009      2008      2009       2008
                                    ----      ----      ----       ----
    Revenue:
      Domestic Product
       Revenue                   $11,296    $8,077   $32,882    $22,807
      Non - U.S. Product
       Revenue                     2,481     1,297     5,897      4,145
                                   -----     -----     -----      -----
    Total Product Revenue:        13,777     9,374    38,779     26,952
      License revenue                 --         9        --         33
                                     ---       ---       ---        ---
    Total revenue                 13,777     9,383    38,779     26,985
      Cost of product revenue      3,659     2,460     9,820      7,545
                                   -----     -----     -----      -----
    Gross profit                  10,118     6,923    28,959     19,440
                                  ------     -----    ------     ------
    Gross profit as a
     % of total revenue               73%       74%       75%        72%
    Operating expenses:
      Research, development
       and clinical                1,630     1,412     4,454      4,708
      Marketing and sales          6,591     6,073    19,783     18,017
      General and administrative   2,019     2,399     6,347      7,270
 
'/>"/>
SOURCE Endologix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Endologix Comments on Alleged Patent Infringement
2. Endologix Responds to Alleged Patent Infringement
3. Endologix to Report Third Quarter 2009 Financial Results on October 27, 2009
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Spherix Reports Second Quarter Earnings
6. Tapestry Reports Second Quarter 2007 Results
7. Callisto Reports on Second-Quarter 2007 Milestones
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
10. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
11. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 /PRNewswire/ - Medicure Inc. (the ... Directors has approved the grant of an aggregate of ... employees and consultants of the Company pursuant to the ... set to expire on the tenth anniversary of the ... the third anniversary of the date of grant and ...
(Date:3/27/2015)... Telbec/ - Russell Williams , President of ... the 2015-2016 Quebec Budget, noting the fiscal discipline and ... industry. However, the association is concerned about the decline ... government,s intent to strive for a balanced budget this ... Quebec,s economic development is encouraging," said ...
(Date:3/27/2015)... Biopharmaceutical Industry Leads Manufacturing Sector in R&D Spending ... as the country,s manufacturing leader in innovation and economic ... to the  analysis , the industry had the highest ... accounting for 27 percent of average annual R&D spending ... on Medicare Part D - Medicare Part D ...
Breaking Medicine Technology:Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 3Week in Review: The Latest from PhRMA 2
... SPEX ) reported that patient recruitment for its Phase ... Naturlose(R), has begun in,India. Expectations for India are to ... the pivotal Phase 3 trial. "Now that enrollment efforts,are ... trial will be completed,on schedule as reported during the ...
... only participant in Texas for TFAS spinal implant, PLANO, ... again in motion preserving technology by continuing to advance,spinal device ... (TFAS)(R)., Dr. Barton Sachs of Texas Back Institute performed ... Texas resident was one of,the first 40 people worldwide to ...
Cached Medicine Technology:Patient Recruitment Begins in India for Phase 3 Diabetes Trial 2Texas Back Institute Leads Way in New Facet Joint Clinical Trial 2
(Date:3/30/2015)... 2015 Bunion Bootie is a ... for family members, friends...and yourself and save. For a limited ... an additional 10%, on top of discounts already offered when ... at checkout. The more Bunion Booties purchased, the more money ... bunion pads, Bunion Bootie can be worn comfortably and easily ...
(Date:3/29/2015)... March 29, 2015 Women’s Excellence ... treatment. Secondary to their location in Birmingham, they ... option. They continue to be affiliated with Crittenton, ... , Menopause is a normal condition that all women ... any of the changes a woman goes through either ...
(Date:3/29/2015)... The Claudia Cohen Research Foundation ... announce today that Dr. Beth Y. Karlan has been ... Research Foundation Prize for Outstanding Gynecologic Researcher. The $50,000 ... Oncology 46th Annual Meeting on Women's Cancer in Chicago. ... Cancer Program at the Samuel Oschin Comprehensive Cancer Institute ...
(Date:3/29/2015)... 2015 Final Cut Pro X ... Pixel Film Studios, entitled TranSports. , “TranSports is ... Final Cut Pro X,” said Christiana Austin, CEO of ... needed to effortlessly transition using this cool sports transition ... and uniquely styled transition pack for Final Cut Pro ...
(Date:3/28/2015)... Tucson, AZ. (PRWEB) March 28, 2015 ... according to a new study by researchers ... (HSPH). , Produced with the support of the Coffee ... the journal Molecular Psychiatry this past fall, the study—one ... a meta-analysis of genomic data from more than 120,000 ...
Breaking Medicine News(10 mins):Health News:Bunion Bootie, the Ultimate Solution for Bunion Relief, Offers Special Savings This Easter 2Health News:Women's Excellence Affiliates with Beaumont Hospital, Treats Menopause 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 3Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 4Health News:Introducing TranSports for Final Cut Pro X Users from Pixel Film Studios 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3
... hay fever symptoms could be reduced by 60% with the ... in Baltimore. ,Dr. Peter Socrates Creticos, medical director ... Johns Hopkins University School of Medicine and his team tested ... ,The study was conducted on 25 volunteers with ...
... health shops to overcome depression only one actually has any ... have said that St John's Wort is the only alternative ... others including gingko biloba, ginseng, cat's claw, royal jelly and ... serious drug interactions". ,The experts, Joyce Reed, a ...
... a dozen top universities on Tuesday by the government ... hasten scientific discoveries towards better health care thereby trying ... ,This idea came about because of the increased specialization ... ever for scientists from different fields to share the ...
... the All India Institute of Medical Sciences (AIIMS), including ... postponed its medical students' semester examination scheduled for later ... their hostel rooms after a seventh semester student died ... virus include medical students, resident doctors and other hospital ...
... and biotech major Wockhardt Limited announced on Tuesday ... $150 million that will help it broaden its presence ... a larger footprint in Europe spread over Britain, Ireland ... ,'European business will now exceed $200 million, accounting for ...
... tuberculosis that caused a major outbreak in a British school ... has surfaced again, directing its destruction on a specific ethnic ... a study to examine the potency of the 2001 outbreak. ... disease with the BCG vaccine. ,The severe strain, ...
Cached Medicine News:Health News:DNA vaccine for ragweed allergies 2Health News:Unscientific Depression Drugs aplenty in Health Stores 2Health News:NIH Funds the Development of National Consortium of Universities 2
... Used for temporary ... ureteropelvic junction to the ... peel-open packages. Intended for ... evaluation is advised; C-Flex® ...
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use....
Used when establishing a percutaneous tract for nephrostomy drainage. The guide has a stiff shaft and a gradual transition to a very flexible distal tip. Supplied sterile in peel-open packages. Inten...
Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: